FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples